全文获取类型
收费全文 | 22921篇 |
免费 | 1106篇 |
国内免费 | 545篇 |
专业分类
耳鼻咽喉 | 1045篇 |
儿科学 | 562篇 |
妇产科学 | 367篇 |
基础医学 | 665篇 |
口腔科学 | 466篇 |
临床医学 | 1790篇 |
内科学 | 1641篇 |
皮肤病学 | 131篇 |
神经病学 | 842篇 |
特种医学 | 402篇 |
外科学 | 9837篇 |
综合类 | 2849篇 |
预防医学 | 1088篇 |
眼科学 | 190篇 |
药学 | 1261篇 |
27篇 | |
中国医学 | 240篇 |
肿瘤学 | 1169篇 |
出版年
2023年 | 366篇 |
2022年 | 632篇 |
2021年 | 818篇 |
2020年 | 756篇 |
2019年 | 768篇 |
2018年 | 703篇 |
2017年 | 628篇 |
2016年 | 623篇 |
2015年 | 734篇 |
2014年 | 1578篇 |
2013年 | 1381篇 |
2012年 | 1529篇 |
2011年 | 1661篇 |
2010年 | 1569篇 |
2009年 | 1496篇 |
2008年 | 1340篇 |
2007年 | 1320篇 |
2006年 | 1096篇 |
2005年 | 975篇 |
2004年 | 798篇 |
2003年 | 604篇 |
2002年 | 527篇 |
2001年 | 449篇 |
2000年 | 327篇 |
1999年 | 248篇 |
1998年 | 195篇 |
1997年 | 166篇 |
1996年 | 174篇 |
1995年 | 111篇 |
1994年 | 103篇 |
1993年 | 82篇 |
1992年 | 47篇 |
1991年 | 62篇 |
1990年 | 49篇 |
1989年 | 38篇 |
1988年 | 33篇 |
1987年 | 31篇 |
1986年 | 43篇 |
1985年 | 57篇 |
1984年 | 63篇 |
1983年 | 41篇 |
1982年 | 45篇 |
1981年 | 34篇 |
1980年 | 37篇 |
1979年 | 44篇 |
1978年 | 47篇 |
1976年 | 27篇 |
1975年 | 33篇 |
1974年 | 26篇 |
1973年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的探讨应用侧胸壁筋膜皮瓣修复乳房外侧象限局部缺损的可行性及美容效果。 方法回顾性分析2016年7月至2018年7月郴州市第一人民医院乳腺甲状腺外科收治的外侧象限乳腺疾病患者46例,其中乳腺癌30例、肉芽肿性乳腺炎10例和交界性叶状肿瘤6例。观察组(26例)采用侧胸壁筋膜皮瓣修复局部缺损,对照组(20例)采用切缘周围脂肪筋膜瓣移位成形修复局部缺损。采用t检验比较2组患者年龄、肿瘤直径、残腔大小、切口长度、手术时间、出血量、引流管留置时间;采用χ2检验比较2组患者肿瘤位置、TNM分期、并发症发生率;采用Kruskal-Wallis秩和检验比较2组患者术后美容效果。 结果2组患者的手术切口长度和引流管留置时间比较,差异有统计学意义(t=18.143、2.197,P均<0.050)。观察组和对照组术后并发症发生率为15.4%(4/26)和20.0%(4/20),2组比较,差异无统计学意义(χ2=0.000,P=0.986)。术后美容效果评价显示观察组优良率为96.2%(25/26),对照组优良率为70.0%(14/20),2组患者优良率比较,差异有统计学意义(χ2=4.138,P=0.042)。术后2组患者美容效果评价比较,差异有统计学意义(H=6.528,P=0.038)。术后所有患者中位随访24个月(12~36个月),均无局部复发及远处转移。 结论采用侧胸壁筋膜皮瓣修复乳房外侧象限局部缺损是可行的,手术可操作性强、创伤小,切口隐蔽及美容效果好,值得临床推广。 相似文献
2.
《European journal of surgical oncology》2022,48(5):1062-1067
BackgroundSurgical resection is recommended for patients with resectable acinar cell carcinoma (ACC). The aim of this study was to investigate the clinical characteristics and surgical outcomes of resectable ACC in comparison to pancreatic ductal adenocarcinoma (PDAC).MethodA retrospective analysis was performed on all patients who consecutively underwent radical resection with pathologically confirmed ACC and PDAC from December 2011 to December 2018. Clinicopathologic characteristics and follow-up information were analyzed. A 1:3 propensity score matching (PSM) method was used to minimize the bias between ACC and PDAC.ResultsA total of 26 patients with ACC and 1351 with PDAC were included. Compared to PDAC, ACC tended to be larger (4.5 vs. 3.0 cm; p < 0.001) and more frequently located in the pancreatic body/tail (61.5% vs. 36.6%, p = 0.009), with lower total bilirubin levels, lower neutrophil lymphocyte ratio (NLR) levels and lower carbohydrate antigen 19-9 (CA19-9) levels and carcinoembryonic antigen (CEA) levels. There was no difference in postoperative morbidities in patients with ACC and PDAC. The median OS and RFS were longer in ACC when compared to PDAC (OS: 43.5 mo vs. 19.0 mo, p = 0.004; RFS: 24.5 mo vs. 11.6 mo, p = 0.023). After the 1:3 PSM, ACC remained to be a better histological type for OS (p = 0.024), but had comparable RFS with PDAC (p = 0.164).ConclusionPatients with ACC after radical resection had better OS than that with PDAC. However, ACC is also an aggressive tumor with a similar trend of RFS with PDAC after the matching, necessitating the multidisciplinary treatment for resectable ACC disease. 相似文献
3.
4.
5.
《Survey of ophthalmology》2023,68(5):940-956
Congenital aniridia is a panocular disorder that is typically characterized by iris hypoplasia and aniridia-associated keratopathy (AAK). AAK results in the progressive loss of corneal transparency and thereby loss of vision. Currently, there is no approved therapy to delay or prevent its progression, and clinical management is challenging because of phenotypic variability and high risk of complications after interventions; however, new insights into the molecular pathogenesis of AAK may help improve its management. Here, we review the current understanding about the pathogenesis and management of AAK. We highlight the biological mechanisms involved in AAK development with the aim to develop future treatment options, including surgical, pharmacological, cell therapies, and gene therapies. 相似文献
6.
《Journal of Cardiovascular Computed Tomography》2022,16(6):517-523
BackgroundSelection of the transcatheter heart valve size for a mitral valve-in-valve procedure is based on the type and manufacturer’s labelled size. However, accurate information of surgical heart valve (SHV) size may not be available in the patient’s medical record. The purpose of this study is to establish reference data for computed tomography (CT) dimensions of commonly used mitral SHV in order to determine the manufacturer’s labelled size from a cardiac CT data set.MethodsCT datasets of 105 patients with surgical mitral bioprosthesis and available manufacturer labeled datasets were included in the analysis. CT derived valve dimensions were assessed by two observers using multiplanar reformats aligned with the basal sewing ring. A circular region of interest was used in a standardized fashion to minimize influence of image acquisition and reconstruction parameters. Interobserver variability was assessed by Bland-Altman analysis.ResultsThe CT-derived dimensions were stratified by valve size and type, and SHV properties were demonstrated for 5 common valve types. Variability of measurements was small and inter-observer limits of agreement were narrow. Stratified by SHV type, no overlap was noted for CT-derived dimensions among different SHV sizes . A reference table of CT characteristics of surgical mitral bioprosthesis types was created.ConclusionThe study provides reference CT data for determining the manufacturers’ labeled SHV size across a range of commonly used mitral SHVs. The findings will be important to help identify types of surgical mitral bioprosthesis utilizing CT characteristics for patients without SHV size documentation. 相似文献
7.
8.
《The Annals of thoracic surgery》2023,115(1):88-95
BackgroundRecent guidelines for the treatment of moderate or severe ischemic mitral regurgitation (IMR) in patients undergoing coronary artery bypass grafting (CABG) have changed. This study assessed the real-world impact of changing guidelines on the management of IMR during CABG over time. We hypothesized that the utilization of mitral valve repair for IMR would decrease over time, whereas mitral valve replacement for severe IMR would increase.MethodsPatients undergoing CABG in a statewide collaborative database (2011-2020) were stratified by severity of IMR. Trends in mitral valve repair or replacement were evaluated. To account for differences of the patients, propensity score–matched analyses were used to compare patients with and without mitral intervention.ResultsA total of 11,676 patients met inclusion criteria, including 1355 (11.6%) with moderate IMR and 390 (3.3%) with severe IMR. The proportion of patients undergoing mitral intervention for moderate IMR decreased over time (2011, 17.7%; 2020, 7.5%; Ptrend = .001), whereas mitral replacement for severe IMR remained stable (2011, 11.1%; 2020, 13.3%; Ptrend = .14). Major morbidity was higher for patients with moderate IMR who underwent mitral intervention (29.1% vs 19.9%; P = .005). In a propensity analysis of 249 well-matched pairs, there was no difference in major morbidity (29.3% with mitral intervention vs 23.7% without; P = .16) or operative mortality (1.2% vs 2.4%; P = .5).ConclusionsConsistent with recent guideline updates, patients with moderate IMR were less likely to undergo mitral repair. However, the rate of replacement for severe IMR did not change. Mitral intervention during CABG did not increase operative mortality or morbidity. 相似文献
9.
10.
目的探讨外伤性硬脑膜外血肿患者采取微创引流术治疗的临床效果。方法选取沈阳市第一人民医院神经外科2019年6月-2020年12月收治的82例外伤性硬脑膜外血肿患者,依据治疗方案的不同分为观察组和对照组各41例。观察组行微创引流术治疗,对照组行传统开颅血肿清除术治疗。观察并比较两组手术相关指标、住院时间和并发症发生情况,以及治疗前后格拉斯哥昏迷量表评分情况。结果观察组的手术时间和住院时间均短于对照组,术中出血量少于对照组,差异均具有统计学意义(P<0.05)。治疗后两组格拉斯哥昏迷量表评分均较治疗前升高,且治疗后观察组格拉斯哥昏迷量表评分高于对照组,差异均具有统计学意义(P<0.05)。观察组并发症发生率低于对照组,差异具有统计学意义(P<0.05)。结论外伤性硬脑膜外血肿患者采取微创引流术治疗与传统开颅手术相比,二者具有同样的治疗效果,但微创引流术的并发症更少,更有利于患者的神经功能恢复,具有临床推广价值。 相似文献